Principles of Data Mining in Toxicogenomics

Toxicogenomics: A Powerful Tool for Toxicity Assessment

Volumn , Issue , 2008, Pages 59-86

  Hirabayashi, Yoko ^a   Inoue, Tohru ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

International Life Science Institute (ILSI) consortium; Murine spontaneous and radiation induced myelogenous leukemias; New risk evaluation strategy and gene expression profile; Radiation specific probabilistic union genes; Single individual gene specific nucleotide polymorphism (SNP); Toxicogenomics and 'expression gene microscope'; Toxicogenomics and data mining principles

Indexed keywords

EID: 84891036915     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470699638.ch3     Document Type: Chapter

References (65)

1. Adams MD, Celniker SE, Holt RA, Evans CA, Gocayne JD, Amanatides PG, Scherer SE, Li PW, Hoskins RA, Galle RF et al. (2000) The genome sequence of Drosophila melanogaster. Science 287, 2185-2195.
2. Albanese J, Martens K, Karkanitsa LV, Dainiak N (2007) Multivariate analysis of low-dose radiationassociated changes in cytokine gene expression profiles using microarray technology. Exp Hematol 35, 47-54.
3. Amiri A, Noei F, Jeganathan S, Kulkarni G, Pinke DE, Lee JM (2007) eEF1A2 activates Akt and stimulates Akt-dependent actin remodeling, invasion and migration. Oncogene 26, 3027-3040.
4. Astrand M (2003) Contrast normalization of oligonucleotide arrays. J Comput Biol 10, 95-102.
5. Bahar R, Hartmann CH, Rodriguez KA, Denny AD, Busuttil RA, Dolle ME, Calder RB, Chisholm GB, Pollock BH, Klein CA, Vijg J (2006) Increased cell-to-cell variation in gene expression in ageing mouse heart. Nature 441, 1011-1014.
6. Bhargava P, Kallakury BV, Ross JS, Azumi N, Bagg A (2007) CD79a is heterogeneously expressed in neoplastic and normal myeloid precursors and megakaryocytes in an antibody clone-dependent manner. Am J Clin Pathol 128, 306-313.
7. Bloomfield VA, Crothers DM, Tinoco I (2000) Nucleic Acids: Structures, Properties, and Functions. University Science Books: Sausalito, CA.
8. Boelens MC, van den Berg A, Vogelzang I, Wesseling J, Postma DS, Timens W, Groen HJ (2007) Differential expression and distribution of epithelial adhesion molecules in non-small cell lung cancer and normal bronchus. J Clin Pathol 60, 608-614.
9. Borlak J (2005) Handbook of Toxicogenomics. Wiley-VCH Verlag: Weinheim.
10. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC et al. (2001) Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 29, 365-371.
11. Brenner S, Jacob F, Meselson M (1961) An unstable intermediate carrying information from genes to ribosomes for protein synthesis. Nature 190, 576-581.
12. Brown PO, Botstein D (1999) Exploring the new world of the genome with DNA microarrays. Nat Genet 21, 33-37.
13. C. elegans Sequencing Consortium (1998) Genome sequence of the nematode C. elegans: a platform for investigating biology. Science 282, 2012-2018.
14. Chang R, Wang E (2007) Mouse translation elongation factor eEF1A-2 interacts with Prdx-I to protect cells against apoptotic death induced by oxidative stress. J Cell Biochem 100, 267-278.
15. Churchill GA (2002) Fundamentals of experimental design for cDNA microarrays. Nat Genet 32 (Suppl.), 490-495.
16. Crick FH (1958) On protein synthesis. Symp Soc Exp Biol 12, 138-163.
17. Crick FH, Barnett L, Brenner S, Watts-Tobin RJ (1961) General nature of the genetic code for proteins. Nature 192, 1227-1232.
18. Cruse JM, Lewis RE, Pierce S, Lam J, Tadros Y (2005) Aberrant expression of CD7, CD56, and CD79a antigens in acute myeloid leukemias. Exp Mol Pathol 79, 39-41.
19. Czapski G, Peled E (1973) Reaction rates of electrons at short times. J Phys Chem 77, 893.
20. Czapski G, Peled E (1975) Reaction rates of electrons at short times. In Radiation Research: Biomedical, Chemical and Physical Perspectives, OF Nygaard, HI Adler, WK Sinclair (eds). Academic Press: New York.
21. Fodor SP, Rava RP, Huang XC, Pease AC, Holmes CP, Adams CL (1993) Multiplexed biochemical assays with biological chips. Nature 364, 555-556.
22. Hamadeh HK, Bushel P, Paules R, Afshari CA (2001) Discovery in toxicology: mediation by gene expression array technology. J Biochem Mol Toxicol 15, 231-242.
23. Hao L, ElShamy WM (2007) BRCA1-IRIS activates cyclin D1 expression in breast cancer cells by downregulating the JNK phosphatase DUSP3/VHR. Int J Cancer 121, 39-46.
24. Harris J, Lowden M, Clejan I, Tzoneva M, Thomas JH, Hodgkin J, Ahmed S (2006) Mutator phenotype of Caenorhabditis elegans DNA damage checkpoint mutants. Genetics 174, 601-616.
25. Hastie ND, Allshire RC (1989) Human telomeres: fusion and interstitial sites. Trends Genet 5, 326-331.
26. Henke FU, Lubarsch O (1924-1952). Handbuch des speziellen pathologischen Anatomie und Histologie, vols 1-12. Springer: Berlin.
27. Hill AA, Brown EL, Whitley MZ, Tucker-Kellogg G, Hunter CP, Slonim DK (2001) Evaluation of normalization procedures for oligonucleotide array data based on spiked cRNA controls. Genome Biol 2, RESEARCH0055.
28. Hourihan RN, O'Sullivan GC, Morgan JG (2003) Transcriptional gene expression profiles of oesophageal adenocarcinoma and normal oesophageal tissues. Anticancer Res 23, 161-165.
29. Hu T, Gibson DP, Carr GJ, Torontali SM, Tiesman JP, Chaney JG, Aardema MJ (2004) Identification of a gene expression profile that discriminates indirect-acting genotoxins from direct-acting genotoxins. Mutat Res 549, 5-27.
30. Hunt JW (1976) Early events in radiation chemistry. In Advances in Radiation Chemistry, vol. 5, M. Burton, JL Magee (eds). John Wiley and Sons, Ltd: New York, p. 185.
31. Inoue T (2003) Introduction: Toxicogenomics-a New Paradigm of Toxocology. In Toxicogenomics, T Inoue, WD Pennie (eds). Springer-Verlag: Tokyo, pp. 3-11.
32. Kong M, Fox CJ, Mu J, Solt L, Xu A, Cinalli RM, Birnbaum MJ, Lindsten T, Thompson CB (2004) The PP2A-associated protein alpha4 is an essential inhibitor of apoptosis. Science 306, 695-698.
33. Kroll TC, Wolfl S (2002) Ranking: a closer look on globalisation methods for normalisation of gene expression arrays. Nucleic Acids Res 30, e50.
34. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W et al. (2001) Initial sequencing and analysis of the human genome. Nature 409, 860-921.
35. Laursen LV, Bjergbaek L, Murray JM, Andersen AH (2003) RecQ helicases and topoisomerase III in cancer and aging. Biogerontology 4, 275-87.
36. Lewin, B (2004) Genes VIII. Pearson Prentice Hall, Upper Saddle River, NJ.
37. Liu Q, Zhao X, Frissora F, Ma Y, Santhanam R, Jarjoura D, Lehman A, Perrotti D, Chen CS, Dalton JT, Muthusamy N, Byrd JC (2007) FTY720 demonstrates promising pre-clinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma. Blood 111, 275-284.
38. Lodish H, Berk A, Matsudaira P, Kaiser C, Krieger M, Scott M, Zipursky SL, Darnell J (2004) Molecular Cell Biology. WH Freeman: New York.
39. Lovett RA (2000) Toxicogenomics. Toxicologists brace for genomics revolution. Science 289, 536-537.
40. Manohar A, Shome SG, Lamar J, Stirling L, Iyer V, Pumiglia K, DiPersio CM (2004) Alpha 3 beta 1 integrin promotes keratinocyte cell survival through activation of a MEK/ERK signaling pathway. J Cell Sci 117, 4043-4054.
41. Nakayama T, Yoshizaki A, Izumida S, Suehiro T, Miura S, Uemura T, Yakata Y, Shichijo K, Yamashita S, Sekin I (2007) Expression of interleukin-11 (IL-11) and IL-11 receptor alpha in human gastric carcinoma and IL-11 upregulates the invasive activity of human gastric carcinoma cells. Int J Oncol 30, 825-833.
42. Neviani P, Santhanam R, Oaks JJ, Eiring AM, Notari M, Blaser BW, Liu S, Trotta R, Muthusamy N, Gambacorti-Passerini C, Druker BJ, Cortes J, Marcucci G, Chen CS, Verrills NM, Roy DC, Caligiuri MA, Bloomfield CD, Byrd JC, Perrotti D (2007) FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia. J Clin Invest 117, 2408-2421.
43. Oh M, Choi IS, Park SD (2002) Topoisomerase III is required for accurate DNA replication and chromosome segregation in Schizosaccharomyces pombe. Nucleic Acids Res 30, 4022-4031.
44. Petersen D, Chandramouli GV, Geoghegan J, Hilburn J, Paarlberg J, Kim CH, Munroe D, Gangi L, Han J, Puri R, Staudt L, Weinstein J, Barrett JC, Green J, Kawasaki ES (2005) Three microarray platforms: an analysis of their concordance in profiling gene expression. BMC Genomics 6, 63.
45. Rahmouni S, Cerignoli F, Alonso A, Tsutji T, Henkens R, Zhu C, Louis-dit-Sully C, Moutschen M, Jiang W, Mustelin T (2006) Loss of the VHR dual-specific phosphatase causes cell-cycle arrest and senescence. Nat Cell Biol 8, 524-531.
46. Schadt EE, Li C, Ellis B, Wong WH (2001) Feature extraction and normalization algorithms for high-density oligonucleotide gene expression array data. J Cell Biochem Suppl 37, 120-125.
47. Seki M, Yoshida K,Nishimura M, Nemoto K(1991) Radiation-induced myeloid leukemia in C3H/He mice and the effect of prednisolone acetate on leukemogenesis. Radiat Res 127, 146-149.
48. Singer M, Berg P (1991) Genes & Genomes: A Changing Perspective. University Science Books: Mill Valley, CA.
49. Storck T, von Brevern MC, Behrens CK, Scheel J, Bach A (2002) Transcriptomics in predictive toxicology. Curr Opin Drug Discov Dev 5, 90-97.
50. Stoyanova R, Querec TD, Brown TR, Patriotis C (2004) Normalization of single-channel DNA array data by principal component analysis. Bioinformatics 20, 1772-1784.
51. Tomlinson VA, Newbery HJ, Bergmann JH, Boyd J, Scott D, Wray NR, Sellar GC, Gabra H, Graham A, Williams AR, Abbott CM(2007) Expression of eEF1A2 is associated with clear cell histology in ovarian carcinomas: overexpression of the gene is not dependent on modifications at the EEF1A2 locus. Br J Cancer 96, 1613-1620.
52. Tsai HJ, Huang WH, Li TK, Tsai YL, Wu KJ, Tseng SF, Teng SC (2006) Involvement of topoisomerase III in telomere-telomere recombination. J Biol Chem 281, 13717-13723.
53. Tsimanis A, Shvidel L, Klepfish A, Shtalrid M, Kalinkovich A, Berrebi A (2001) Over-expression of the functional interleukin-11 alpha receptor in the development of B-cell chronic lymphocytic leukemia. Leuk Lymphoma 42, 195-205.
54. Varis A, Wolf M, Monni O, Vakkari ML, Kokkola A, Moskaluk C, Frierson Jr H, Powell SM, Knuutila S, Kallioniemi A, El-Rifai W (2002) Targets of gene amplification and overexpression at 17q in gastric cancer. Cancer Res 62, 2625-2629.
55. Wassenhove-McCarthy DJ, McCarthy KJ (1999) Molecular characterization of a novel basement membrane-associated proteoglycan, leprecan. J Biol Chem 274, 25004-25017.
56. Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, Agarwal P, Agarwala R, Ainscough R, Alexandersson M, An P et al. (2002) Initial sequencing and comparative analysis of the mouse genome. Nature 420, 520-562.
57. Watson JD, Baker TA, Bell SP, Gann A, Levine M, Losick T (2007) Molecular Biology of the Gene. Pearson/Benjamin Cummings: San Francisco, CA.
58. Watson JD, Crick FH (1953) Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature 171, 737-738.
59. Yoshida K, Inoue T, NojimaK,Hirabayashi Y, Sado T (1997) Calorie restriction reduces the incidence of myeloid leukemia induced by a single whole-body radiation in C3H/He mice. Proc Natl Acad Sci U S A 94, 2615-2619.
60. Yoshizaki A, Nakayama T, Yamazumi K, Yakata Y, Taba M, Sekine I (2006). Expression of interleukin (IL)-11 and IL-11 receptor in human colorectal adenocarcinoma: IL-11 up-regulation of the invasive and proliferative activity of human colorectal carcinoma cells. Int J Oncol 29, 869-876.
61. Yu L, Liu C, Vandeusen J, Becknell B, Dai Z, Wu YZ, Raval A, Liu TH, Ding W, Mao C, Liu S, Smith LT, Lee S, Rassenti L,Marcucci G, Byrd J, CaligiuriMA, Plass C (2005) Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia. Nat Genet 37, 265-274.
62. Yun K, Mantani A, Garel S, Rubenstein J, Israel MA (2004) Id4 regulates neural progenitor proliferation and differentiation in vivo. Development 131, 5441-5448.
63. Yunis JJ, Soreng AL, Bowe AE (1987) Fragile sites are targets of diverse mutagens and carcinogens. Oncogene 1, 59-69.
64. Zhang W, Shmulevich I (2006) Computational and Statistical Approaches to Genomics. Springer Science+Business Media: New York.
65. Zurita AJ, Troncoso P, Cardo-Vila M, Logothetis CJ, Pasqualini R, Arap W (2004) Combinatorial screenings in patients: the interleukin-11 receptor alpha as a candidate target in the progression of human prostate cancer. Cancer Res 64, 435-439.